Fusion Antibodies Ltd (FAB) ORD GBP0.04
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
12.00p
12.50p
20.50p
£15.00 million
12.00p
11.26p
5.80p
n/a
0.50p (4.00%) Previous:
0.50p
556,598
n/a
30,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/03/2025 | 31/03/2024 |
|---|---|---|
| Revenue (£m) | 1.97 | 1.14 |
| Profit before tax (£m) | (1.78) | (2.29) |
| Adjusted EPS (p): | (1.80) | (3.90) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies enters deal to transfer IP to client
30 March 2026 11:07
-
Fusion Antibodies posts narrower half-year loss
24 November 2025 12:54
-
Fusion Antibodies expecting stronger second-half performance
16 October 2025 15:42
-
Antibody IP transfer agreement
30 March 2026 07:00
-
Director/PDMR Shareholding
17 February 2026 11:42
-
Holding(s) in Company
4 February 2026 15:27
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.